Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jennifer Specht
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Yuma Cancer Center
Yuma, Arizona, United States
- Saint Joseph Regional Medical Center
Lewiston, Idaho, United States
- Bozeman Deaconess Hospital
Bozeman, Montana, United States
- Kalispell Regional Medical Center
Kalispell, Montana, United States
- Bend Memorial Clinic
Bend, Oregon, United States
- Kadlec Clinic Hematology and Oncology
Kennewick, Washington, United States
- Evergreen Hospital Medical Center
Kirkland, Washington, United States
- Skagit Valley Hospital Regional Cancer Care Center
Mount Vernon, Washington, United States
- Group Health Cooperative, Redmond
Redmond, Washington, United States
- Fred Hutchinson Cancer Research Center/university of Washington Cancer Consortium
Seattle, Washington, United States
- Olympic Medical Cancer Care Center
Sequim, Washington, United States
- Spokane Valley Cancer Center-Mayfair
Spokane, Washington, United States
- Multicare Medical Oncology Hematology
Tacoma, Washington, United States
- Wenatchee Valley Medical Center
Wenatchee, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Apr 2008
- Primary completion
- 5 Jul 2017
- Completion
- 28 Sept 2017
- Last update posted
- 4 Dec 2018
- Registered enrollment
- 59
- Registry id
- NCT00733408
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.